(Q34053028)

30 July 2017

Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy (English)

1 reference

30 July 2017

0 references

0 references

Robert M Prins

2

0 references

Timothy F. Cloughesy

17

object named as

Timothy F Cloughesy

1 reference

30 July 2017

16

Albert Lai

1 reference

30 July 2017

21

Linda M Liau

1 reference

30 July 2017

7

Noriko Salamon

1 reference

30 July 2017

1

Whitney B Pope

1 reference

30 July 2017

18

Harley I Kornblum

1 reference

30 July 2017

M Albert Thomas

3

1 reference

30 July 2017

Rajakumar Nagarajan

4

1 reference

30 July 2017

Katharine E Yen

5

1 reference

30 July 2017

Mark A Bittinger

6

1 reference

30 July 2017

Arthur P Chou

8

1 reference

30 July 2017

William H Yong

9

1 reference

30 July 2017

Horacio Soto

10

1 reference

30 July 2017

Neil Wilson

11

1 reference

30 July 2017

Edward Driggers

12

1 reference

30 July 2017

Hyun G Jang

13

1 reference

30 July 2017

Shinsan M Su

14

1 reference

30 July 2017

David P Schenkein

15

1 reference

30 July 2017

Hong Wu

19

1 reference

30 July 2017

Valeria R Fantin

20

1 reference

30 July 2017

language of work or name

1 reference

21 October 2011

1 reference

Journal of Neuro-Oncology

30 July 2017

1 reference

30 July 2017

107

1 reference

30 July 2017

1

1 reference

30 July 2017

197-205

1 reference

describes a project that uses

30 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-011-0737-8

0 references

cites work

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH mutations in glioma and acute myeloid leukemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Prognostic markers in gliomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Proton magnetic resonance spectroscopy imaging in the study of human brain cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 and IDH2 mutations in gliomas

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Analysis of the IDH1 codon 132 mutation in brain tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

An integrated genomic analysis of human glioblastoma multiforme

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

The principles of quantification applied to in vivo proton MR spectroscopy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Cramér-Rao bounds: an evaluation tool for quantitation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Spatial localization in NMR spectroscopy in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

IDH1 and IDH2 mutations in gliomas.

5 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Molecular signatures classify astrocytic gliomas by IDH1 mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0737-8

Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3650613

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22015945

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11060-011-0737-8

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference